Cognitive protection of incretin ‐based therapies in patients with type 2 diabetes mellitus: A systematic review and meta‐analysis based on clinical studies

ConclusionsCurrent evidence shows that incretin-based therapies might be more effective, when compared with the other hypoglycemic drugs, for cognitive improvement in patients with type  2 diabetes mellitus.

Source: Journal of Diabetes Investigation - May 6, 2023 Category: Endocrinology Authors: Sanbao Chai, Fengqi Liu, Shuqing Yu, Zhirong Yang, Feng Sun Tags: Original Article Source Type: research